Literature DB >> 28820853

Reply.

Ilkay K Muftuoglu1, Mostafa Alam, Qi Sheng You, Raouf Gaber, Hema L Ramkumar, Nadia Mendoza, Amit Meshi, William R Freeman.   

Abstract

Entities:  

Year:  2017        PMID： 28820853      PMCID： PMC5847275          DOI： 10.1097/IAE.0000000000001814

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  4 in total

1.  Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Authors:  Ebenezer Daniel; James Shaffer; Gui-shuang Ying; Juan E Grunwald; Daniel F Martin; Glenn J Jaffe; Maureen G Maguire
Journal:  Ophthalmology       Date:  2015-12-08       Impact factor: 12.079

2.  High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.

Authors:  Ilkay Kilic Muftuoglu; Frank F Tsai; Raouf Gaber; Mostafa Alam; Amit Meshi; William R Freeman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-23       Impact factor: 3.117

3.  Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Maureen G Maguire; Daniel F Martin; Gui-Shuang Ying; Glenn J Jaffe; Ebenezer Daniel; Juan E Grunwald; Cynthia A Toth; Frederick L Ferris; Stuart L Fine
Journal:  Ophthalmology       Date:  2016-05-02       Impact factor: 12.079

4.  LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.

Authors:  Ilkay Kilic Muftuoglu; Mostafa Alam; Qi Sheng You; Raouf Gaber; Hema L Ramkumar; Nadia Mendoza; Amit Meshi; William R Freeman
Journal:  Retina       Date:  2018-03       Impact factor: 4.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.